India’s push to lead in gene therapy clinical progress took center stage in Parliament today as officials from the government detailed how the country is advancing cutting edge treatments while relying on a firm regulatory system.
Lupin Manufacturing Solutions announces the expansion of its Dabhasa facility to enhance peptide and CRDMO capabilities, supporting global demand for complex therapeutics and drug development.
.png "Natco's Affordable Semaglutide Shakes India's Drug Market at INR 1,290")
Natco Pharma has just shaken up the India’s diabetes drug market with its launch of semaglutide at just INR 1,290 a month, making high end diabetes treatment far more affordable for millions.
Tata Elxsi and Terumo Corporation have launched the Terumo–Tata Elxsi Offshore Development Centre to strengthen global support for cardiac and vascular solutions.
Pfizer Inc. has announced positive topline results from its phase 3 TALAPRO-3 study, highlighting the impact of Talzenna Xtandi trial outcomes in advanced prostate cancer.
Indian pharma manufacturers are pushing for input price caps as raw material costs surge sharply. Smaller companies warn that without support, rising expenses and tight drug price controls could disrupt medicine supply.
Akums Drugs & Pharmaceuticals has launched Lasmiditan dispersible tablet aimed at providing faster and easier relief during acute migraine attacks.
Merck reveals new clinical data on heart and lung diseases at ACC.26, showcasing promising treatments for high cholesterol and heart failure, offering hope for millions.
.png "Zydus & Torrent Partner to Co-Market Semaglutide Injection")
Zydus Lifesciences Limited and Torrent Pharmaceuticals Limited today announced a licensing and supply agreement to co market semaglutide injection in India.
Indian pharma major Strides Pharma Science has announced a significant Strides Pharma Africa expansion by acquiring a portfolio of branded generic medicines from Sandoz AG.
.jpg)
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")